Dr. Bijal Modi, M.D.
What this data tells you about Dr. Modi
Dr. Bijal Modi is a hematology & oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Modi performed 74,337 Medicare services across 4,060 unique beneficiaries.
Between the years covered by Open Payments, Dr. Modi received a total of $782 from 25 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Modi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 12,550 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 11,850 | $0 | $5 |
| Paclitaxel chemotherapy injection | 9,454 | $0 | $8 |
| Iron sucrose injection (Venofer) | 9,200 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 7,700 | $43 | $137 |
| Daratumumab injection (Darzalex) | 5,400 | $38 | $127 |
| Immune globulin infusion (Octagam) | 2,210 | $34 | $235 |
| Dexamethasone injection (steroid) | 1,532 | $0 | $1 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,510 | $21 | $181 |
| Blood draw (venipuncture) | 1,480 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,402 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,337 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,060 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 940 | $0 | $24 |
| Office visit, established patient (30-39 min) | 517 | $93 | $368 |
| Office visit, established patient (20-29 min) | 390 | $64 | $250 |
| Injection, carboplatin, 50 mg | 380 | $2 | $300 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 372 | $71 | $1,348 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 337 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 315 | $105 | $707 |
| Office visit, established patient, complex (40-54 min) | 308 | $134 | $496 |
| Immunoglobulin level test | 300 | $9 | $56 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 241 | $3 | $373 |
| Measurement of immunoglobulin light chains | 224 | $17 | $60 |
| Injection, zoledronic acid, 1 mg | 212 | $7 | $431 |
| Injection, potassium chloride, per 2 meq | 205 | $0 | $1 |
| Ferritin level test (iron stores) | 163 | $13 | $60 |
| Iron level test | 157 | $6 | $27 |
| Iron binding capacity test | 157 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 146 | $50 | $313 |
| Drug injection, under skin or into muscle | 138 | $11 | $96 |
| Injection of additional new drug or substance into vein | 137 | $12 | $108 |
| Lactate dehydrogenase (enzyme) level | 136 | $6 | $31 |
| Infusion, normal saline solution , 1000 cc | 119 | $2 | $19 |
| PSA test (prostate cancer screening) | 118 | $18 | $94 |
| Injection, diphenhydramine hcl, up to 50 mg | 113 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 104 | $23 | $161 |
| Injection, magnesium sulfate, per 500 mg | 102 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 99 | $51 | $344 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 89 | $20 | $128 |
| Hospital follow-up visit, moderate complexity | 82 | $62 | $247 |
| Carcinoembryonic antigen (cea) protein level | 81 | $18 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 76 | $16 | $100 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 74 | $58 | $211 |
| Hospital follow-up visit, high complexity | 71 | $94 | $357 |
| Microscopic examination for white blood cells with manual cell count | 62 | $4 | $22 |
| Complete blood count (CBC), automated | 62 | $6 | $34 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 60 | $20 | $128 |
| Unclassified drugs | 60 | $1 | $8 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | $25 | $145 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 53 | $1 | $19 |
| Red blood count automated, with additional calculations | 51 | $5 | $26 |
| New patient office visit, complex (60-74 min) | 46 | $157 | $709 |
| Infusion into a vein for hydration, 31-60 minutes | 42 | $26 | $256 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 41 | $122 | $3,675 |
| New patient office visit (45-59 min) | 37 | $112 | $565 |
| Infusion into a vein for hydration, each additional hour | 36 | $10 | $75 |
| Application of on-body injector for under skin injection | 29 | $15 | $96 |
| Urinalysis with microscopic exam | 26 | $3 | $28 |
| Administration of additional new drug or substance into vein using push technique | 25 | $44 | $289 |
| Irrigation of implanted venous access drug delivery device | 23 | $20 | $114 |
| Drawing of blood for a medical problem | 19 | $74 | $264 |
| Initial hospital admission, high complexity | 19 | $136 | $694 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Modi is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Modi experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Modi receive payments from pharmaceutical companies?
How do Dr. Modi's costs compare to other hematology & oncology specialists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology